Squarepoint Ops LLC Bristol Myers Squibb CO Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Squarepoint Ops LLC holds 54,584 shares of BMY stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,584

Previous 347,200 84.28%

Holding current value

$3.21 Million

Previous $14.4 Million 80.41%

% of portfolio

0.0%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $155 Million - $203 Million	-3,914,635 Reduced 98.62%	54,584 $2.82 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $138 Million - $182 Million	3,435,412 Added 643.57%	3,969,219 $165 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $147 Million - $166 Million	-3,055,428 Reduced 85.13%	533,807 $28.9 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $126 Million - $150 Million	2,598,196 Added 262.17%	3,589,235 $184 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $61.9 Million - $68.7 Million	970,996 Added 4844.56%	991,039 $63.4 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $55.4 Million - $62.9 Million	-843,730 Reduced 97.68%	20,043 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $48.1 Million - $56.9 Million	702,166 Added 434.49%	863,773 $62.1 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $39,240 - $23.2 Million	-301,847 Reduced 65.13%	161,607 $11.5 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $14.5 Million - $15.9 Million	199,065 Added 75.29%	463,454 $35.7 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $32.3 Million - $38.8 Million	-525,780 Reduced 66.54%	264,389 $19.3 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $10.4 Million - $12.1 Million	193,153 Added 32.35%	790,169 $49.3 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $18.4 Million - $21.6 Million	311,549 Added 109.14%	597,016 $35.3 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $24.2 Million - $26.4 Million	-391,215 Reduced 57.81%	285,467 $19.1 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $17.6 Million - $19.8 Million	296,107 Added 77.81%	676,682 $42.7 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $5.3 Million - $6.01 Million	-91,859 Reduced 19.44%	380,575 $23.6 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $5.35 Million - $5.93 Million	-93,159 Reduced 16.47%	472,434 $28.5 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $21.7 Million - $25.4 Million	396,192 Added 233.88%	565,593 $33.3 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $2.82 Million - $4.09 Million	60,701 Added 55.84%	169,401 $9.44 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $2.81 Million - $3.67 Million	57,197 Added 111.06%	108,700 $6.98 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $28.2 Million - $31.2 Million	-632,824 Reduced 92.47%	51,503 $2.34 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $25.6 Million - $30.5 Million	567,427 Added 485.4%	684,327 $32.6 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.84 Million - $2.39 Million	-37,759 Reduced 24.41%	116,900 $6.08 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $3.13 Million - $3.53 Million	56,759 Added 57.98%	154,659 $9.6 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $1.5 Million - $1.87 Million	-29,703 Reduced 23.28%	97,900 $5.42 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $8.17 Million - $9.41 Million	-136,418 Reduced 51.67%	127,603 $8.07 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $15.8 Million - $17.3 Million	264,021	264,021 $16.2 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Bristol Myers Squibb CO Transaction History